Precision medicine is revolutionizing healthcare by tailoring interventions to individual patients based on their unique genetic and proteomic profiles. Genomics, the study of an organism's complete set of DNA, allows us to identify disease-causing mutations and predict an individual's susceptibility to certain conditions. Proteomics, conversely, f

below both Drake’s and Lynch’s models, the cost of deleterious mutations is exactly what drives mutation costs down (Drake 1991; Lynch 2010; Sung et al. 2012). Therefore, less than both equally designs, an increase in the average expense of mutations would produce a lessen in mutation prices. to look at this, Drake examined mutation prices of t